Literature DB >> 1727742

NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice.

M Prochazka1, D V Serreze, W N Frankel, E H Leiter.   

Abstract

NOR/Lt is an insulitis-resistant and diabetes-free strain produced from an isolated genetic contamination within an NOD/Lt pedigree line. The albino coat-color phenotype, strain-specific endogenous retroviral profile, and skin graft tests indicated an NOD/Lt x C57BL/KsJ outcross-backcross segregant as the source of the contaminating genome. Analysis of 53 polymorphic DNA, biochemical, and immunologic markers distinguishing NOD/Lt from C57BL/KsJ revealed that 4 chromosomes (chromosomes 2, 4, 11, and 12) in NOR/Lt contained C57BL/KsJ-derived genes. The remaining markers on 14 chromosomes, including the diabetogenic H-2g7 complex on chromosome 17, were of NOD origin. Although completely resistant to cyclophosphamide-induced diabetes, NOR/Lt mice exhibited the same peripheral T-lymphocyte accumulation characteristic of NOD/Lt. Similarly, NOR/Lt peritoneal macrophages exhibited depressed interleukin-1 secretion characteristic of NOD/Lt. In addition to their diabetes resistance, NOR/Lt mice were distinguished from NOD/Lt by exhibiting more robust suppressor T-lymphocyte function. Outcross of NOR/Lt with NOD/Lt to generate heterozygosity at those chromosomal segments, defined by C57BL/KsJ markers in NOR/Lt parentals, did not produce insulitis or diabetes in F1 females. However, these F1 females were sensitive to cyclophosphamide-induced diabetes. In summary, the NOR/Lt strain is an MHC-matched diabetes-resistant control strain for NOD/Lt. Moreover, NOR/Lt will help identify the location and function of a non-MHC gene or genes capable of conferring resistance against insulitis and diabetes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727742     DOI: 10.2337/diab.41.1.98

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  43 in total

1.  Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice.

Authors:  H R Gaskins; M Prochazka; K Hamaguchi; D V Serreze; E H Leiter
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

2.  Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

Authors:  Kirsty Brown; Artem Godovannyi; Caixia Ma; YiQun Zhang; Zahra Ahmadi-Vand; Chaunbin Dai; Monika A Gorzelak; YeeKwan Chan; Justin M Chan; Arion Lochner; Jan P Dutz; Bruce A Vallance; Deanna L Gibson
Journal:  ISME J       Date:  2015-08-14       Impact factor: 10.302

3.  Subcongenic analysis of genetic basis for impaired development of invariant NKT cells in NOD mice.

Authors:  Yi-Guang Chen; John P Driver; Pablo A Silveira; David V Serreze
Journal:  Immunogenetics       Date:  2007-07-10       Impact factor: 2.846

4.  Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes.

Authors:  Paolo Fiorina; Mollie Jurewicz; Andrea Augello; Andrea Vergani; Shirine Dada; Stefano La Rosa; Martin Selig; Jonathan Godwin; Kenneth Law; Claudia Placidi; R Neal Smith; Carlo Capella; Scott Rodig; Chaker N Adra; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  A recombination hotspot leads to sequence variability within a novel gene (AK005651) and contributes to type 1 diabetes susceptibility.

Authors:  Iris K L Tan; Leanne Mackin; Nancy Wang; Anthony T Papenfuss; Colleen M Elso; Michelle P Ashton; Fiona Quirk; Belinda Phipson; Melanie Bahlo; Terence P Speed; Gordon K Smyth; Grant Morahan; Thomas C Brodnicki
Journal:  Genome Res       Date:  2010-11-04       Impact factor: 9.043

6.  Characterization of a mouse model of islet transplantation using MIN-6 cells.

Authors:  Douglas O Sobel; Barath Ramasubramanian; Larry Mitnaul
Journal:  Islets       Date:  2020-06-22       Impact factor: 2.694

7.  Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region.

Authors:  F Colucci; M L Bergman; C Penha-Gonçalves; C M Cilio; D Holmberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

8.  Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.

Authors:  Mollie Jurewicz; Sunmi Yang; Andrea Augello; Jonathan G Godwin; Robert F Moore; Jamil Azzi; Paolo Fiorina; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

9.  An efficient SNP system for mouse genome scanning and elucidating strain relationships.

Authors:  Petko M Petkov; Yueming Ding; Megan A Cassell; Weidong Zhang; Gunjan Wagner; Evelyn E Sargent; Steven Asquith; Victor Crew; Kevin A Johnson; Phil Robinson; Valerie E Scott; Michael V Wiles
Journal:  Genome Res       Date:  2004-09       Impact factor: 9.043

10.  Regulatory function of a novel population of mouse autoantigen-specific Foxp3 regulatory T cells depends on IFN-gamma, NO, and contact with target cells.

Authors:  Cyndi Chen; Chih-Pin Liu
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.